finance.yahoo.com
Walmart announced it is closing down its healthcare business Tuesday. The move will impact 51 locations in five states, as well as relationships with health ...
4 days ago
finance.yahoo.com
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company’s earnings today.
9 days ago
finance.yahoo.com
J&J is doubling down on medtech, a typically sleepy sector that has been risky, as it looks to grow after spinning of consumer health segment Kenvue.
18 days ago
finance.yahoo.com
From the Dobbs decision, the Supreme Court ruling that overturned Roe v. Wade, to fostering more competition in healthcare, the US Department of Health and...
22 days ago
finance.yahoo.com
Pfizer (PFE) has released the results from its Phase 3 clinical trial for its RSV vaccine. The trial showed positive outcomes for adults aged 18-59, widening...
25 days ago
finance.yahoo.com
Shares of Teladoc Health (TDOC) are under pressure Friday, following the announcement that CEO Jason Gorevic will be stepping down after a 15-year tenure at ...
29 days ago
finance.yahoo.com
Walgreens is in the middle of a turnaround strategy. CEO Tim Wentworth sat down with Yahoo Finance to discuss the company’s new focus.
about 1 month ago
Search by beat, location, outlet & position to find the right journalists for your story.
Sign up for freefinance.yahoo.com
The Food and Drug Administration has approved Winrevair, Merck’s (MRK) latest drug to treat pulmonary arterial hypertension, a lung condition. Investors have...
about 1 month ago
finance.yahoo.com
Moderna (MRNA) is advancing three of its vaccines into Phase Three trials as the pharmaceutical giant hopes to expand its product pipeline past its COVID-19 ...
about 1 month ago
finance.yahoo.com
Viking Therapeutics is gearing up to compete with market GLP-1 leaders Novo Nordisk and Eli Lilly.
about 1 month ago
finance.yahoo.com
PBMs have used various strategies over the years to squeeze independent pharmacies, and these tactics are on the rise as the federal government takes aim at ...
about 1 month ago
finance.yahoo.com
AstraZeneca (AZN) has announced its plans to acquire Fusion Pharmaceuticals (FUSN), a Canadian drug developer, in an all-cash deal valued at $2 billion. This...
about 2 months ago
finance.yahoo.com
Moody’s says pharma and medical device companies are most likely to see the earliest benefits from adopting AI technology.
about 2 months ago
finance.yahoo.com
UnitedHealth Group’s recent cyberattack and DOJ probe are unlikely to be long-term headwinds, according to a BoA analyst.
about 2 months ago
finance.yahoo.com
UnitedHealth Group faced a cyberattack that froze an important subsidiary in the healthcare ecosystem.
about 2 months ago
finance.yahoo.com
UnitedHealth Group’s Change Healthcare subsidiary is expected to have a “material update” as early as Tuesday following a major ransomware attack that’s now ...
2 months ago
finance.yahoo.com
Novavax has resolved a potentially expensive battle with Gava, opening up a pathway for the company to get out of the red.
2 months ago
finance.yahoo.com
Moderna posted strong results despite investors assuming a loss for the year.
2 months ago
finance.yahoo.com
CVS is bullish on its health services outlook, even as the broader industry faces pressure.
3 months ago
finance.yahoo.com
Health insurer Oscar Health says it’s going to be profitable in 2024.
3 months ago
finance.yahoo.com
Amgen is focused on price declines while it looks to fill out its portfolio and chase the new obesity market.
3 months ago